Literature DB >> 27289557

TET2-mediated 5-hydroxymethylcytosine induces genetic instability and mutagenesis.

Emna Mahfoudhi1, Ibtissam Talhaoui2, Xenia Cabagnols3, Véronique Della Valle3, Lise Secardin3, Philippe Rameau4, Olivier A Bernard3, Alexander A Ishchenko2, Salem Abbes5, William Vainchenker3, Murat Saparbaev2, Isabelle Plo6.   

Abstract

The family of Ten-Eleven Translocation (TET) proteins is implicated in the process of active DNA demethylation and thus in epigenetic regulation. TET 1, 2 and 3 proteins are oxygenases that can hydroxylate 5-methylcytosine (5-mC) into 5-hydroxymethylcytosine (5-hmC) and further oxidize 5-hmC into 5-formylcytosine (5-fC) and 5-carboxylcytosine (5-caC). The base excision repair (BER) pathway removes the resulting 5-fC and 5-caC bases paired with a guanine and replaces them with regular cytosine. The question arises whether active modification of 5-mC residues and their subsequent elimination could affect the genomic DNA stability. Here, we generated two inducible cell lines (Ba/F3-EPOR, and UT7) overexpressing wild-type or catalytically inactive human TET2 proteins. Wild-type TET2 induction resulted in an increased level of 5-hmC and a cell cycle defect in S phase associated with higher level of phosphorylated P53, chromosomal and centrosomal abnormalities. Furthermore, in a thymine-DNA glycosylase (Tdg) deficient context, the TET2-mediated increase of 5-hmC induces mutagenesis characterized by GC>AT transitions in CpG context suggesting a mutagenic potential of 5-hmC metabolites. Altogether, these data suggest that TET2 activity and the levels of 5-hmC and its derivatives should be tightly controlled to avoid genetic and chromosomal instabilities. Moreover, TET2-mediated active demethylation might be a very dangerous process if used to entirely demethylate the genome and might rather be used only at specific loci.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  5-hmC; Cell cycle; Genetic instability; TDG; TET2

Mesh:

Substances:

Year:  2016        PMID: 27289557     DOI: 10.1016/j.dnarep.2016.05.031

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  10 in total

Review 1.  A chromatin perspective on metabolic and genotoxic impacts on hematopoietic stem and progenitor cells.

Authors:  Zhenhua Yang; Hao Jiang
Journal:  Cell Mol Life Sci       Date:  2020-04-21       Impact factor: 9.261

Review 2.  Enzyme-free targeted DNA demethylation using CRISPR-dCas9-based steric hindrance to identify DNA methylation marks causal to altered gene expression.

Authors:  Daniel M Sapozhnikov; Moshe Szyf
Journal:  Nat Protoc       Date:  2022-10-07       Impact factor: 17.021

3.  Consequences of mutant TET2 on clonality and subclonal hierarchy.

Authors:  Cassandra M Hirsch; Aziz Nazha; Kassy Kneen; Mohamed E Abazeed; Manja Meggendorfer; Bartlomiej P Przychodzen; Niroshan Nadarajah; Vera Adema; Yasunobu Nagata; Abhinav Goyal; Hassan Awada; Mohammad Fahad Asad; Valeria Visconte; Yihong Guan; Mikkael A Sekeres; Ryszard Olinski; Babal Kant Jha; Thomas LaFramboise; Tomas Radivoyevitch; Torsten Haferlach; Jaroslaw P Maciejewski
Journal:  Leukemia       Date:  2018-05-24       Impact factor: 12.883

4.  The Ageing Brain: Effects on DNA Repair and DNA Methylation in Mice.

Authors:  Sabine A S Langie; Kerry M Cameron; Gabriella Ficz; David Oxley; Bartłomiej Tomaszewski; Joanna P Gorniak; Lou M Maas; Roger W L Godschalk; Frederik J van Schooten; Wolf Reik; Thomas von Zglinicki; John C Mathers
Journal:  Genes (Basel)       Date:  2017-02-17       Impact factor: 4.096

Review 5.  Mitochondria in the signaling pathways that control longevity and health span.

Authors:  Mansour Akbari; Thomas B L Kirkwood; Vilhelm A Bohr
Journal:  Ageing Res Rev       Date:  2019-08-12       Impact factor: 10.895

Review 6.  Targeting DNA Repair Pathways in Hematological Malignancies.

Authors:  Jehad F Alhmoud; Ayman G Mustafa; Mohammed Imad Malki
Journal:  Int J Mol Sci       Date:  2020-10-06       Impact factor: 5.923

7.  Somatic gene mutations expose cytoplasmic DNA to co-opt the cGAS/STING/NLRP3 axis in myelodysplastic syndromes.

Authors:  Amy F McLemore; Hsin-An Hou; Benjamin S Meyer; Nghi B Lam; Grace A Ward; Amy L Aldrich; Matthew A Rodrigues; Alexis Vedder; Ling Zhang; Eric Padron; Nicole D Vincelette; David A Sallman; Omar Abdel-Wahab; Alan F List; Kathy L McGraw
Journal:  JCI Insight       Date:  2022-08-08

8.  The HDAC7-TET2 epigenetic axis is essential during early B lymphocyte development.

Authors:  Alba Azagra; Ainara Meler; Oriol de Barrios; Laureano Tomás-Daza; Olga Collazo; Beatriz Monterde; Mireia Obiols; Llorenç Rovirosa; Maria Vila-Casadesús; Mónica Cabrera-Pasadas; Mar Gusi-Vives; Thomas Graf; Ignacio Varela; José Luis Sardina; Biola M Javierre; Maribel Parra
Journal:  Nucleic Acids Res       Date:  2022-08-26       Impact factor: 19.160

9.  Direct observation and analysis of TET-mediated oxidation processes in a DNA origami nanochip.

Authors:  Xiwen Xing; Shinsuke Sato; Nai-Kei Wong; Kumi Hidaka; Hiroshi Sugiyama; Masayuki Endo
Journal:  Nucleic Acids Res       Date:  2020-05-07       Impact factor: 16.971

10.  Benzene metabolites trigger pyroptosis and contribute to haematotoxicity via TET2 directly regulating the Aim2/Casp1 pathway.

Authors:  Xiaoli Guo; Wen Zhong; Yujiao Chen; Wei Zhang; Jing Ren; Ai Gao
Journal:  EBioMedicine       Date:  2019-08-29       Impact factor: 8.143

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.